Salim Wehbe
Urogynecology and Reconstructive Pelvic Surgery Sacramento, CA Medical Doctor
NPI 1699714626 CMS profile 212726
4860 Y St Ste 2500, Ambulatory Care Center, Ob/Gyn Clinic, Uc Davis, Sacramento, CA 95817
General payments
$262
Research payments
$0
Ownership & investment interest
$80,000
Through program year 2024, Salim Wehbe of Sacramento, CA is reported in the CMS Open Payments database as having received $262 across 3 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $80,000 across 4 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 9th percentile of Urogynecology and Reconstructive Pelvic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $80 | 1 | |
| 2023 | General | $146 | 1 | |
| 2021 | General | $36 | 1 | |
| 2025 | Ownership | $20,000 | 1 | |
| 2024 | Ownership | $20,000 | 1 | |
| 2023 | Ownership | $20,000 | 1 | |
| 2022 | Ownership | $20,000 | 1 |
Beside peers
- Salim Wehbe
- Urogynecology and Reconstructive Pelvic Surgery median
- Middle half of Urogynecology and Reconstructive Pelvic Surgery
- National median
In program year 2025, general payments to Salim Wehbe were reported at $0. Among 802 Urogynecology and Reconstructive Pelvic Surgery profiles paid that year, the median was $412 and the middle half received between $133 and $1,300.
Show as a table
| Year | Salim Wehbe | Urogynecology and Reconstructive Pelvic Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $358 | $132–$1,270 | $163 |
| 2020 | $0 | $198 | $86–$642 | $114 |
| 2021 | $36 | $361 | $118–$1,182 | $132 |
| 2022 | $0 | $410 | $128–$1,175 | $149 |
| 2023 | $146 | $434 | $152–$1,344 | $160 |
| 2024 | $80 | $494 | $193–$1,331 | $164 |
| 2025 | $0 | $412 | $133–$1,300 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 16 drugsPart D claims
1,385
Drug cost
$150,232
Branded share of claims
31.1%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Myrbetriq Mirabegron | Brand | 98 | $67,374 | |
| Yuvafem Estradiol | Brand | 208 | $20,562 | |
| Estradiol | Generic | 342 | $15,898 | |
| Mirabegron Er Mirabegron | Brand | 35 | $13,815 | |
| Trospium Chloride | Generic | 197 | $12,247 | |
| Estring Estradiol | Brand | 16 | $9,788 | |
| Methenamine Hippurate | Generic | 82 | $4,844 | |
| Solifenacin Succinate | Generic | 57 | $1,545 | |
| Cephalexin | Generic | 106 | $1,221 | |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | Brand | 56 | $651 |
The 10 drugs with the highest cost, of 16 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 138 Part D prescribers listed as Undefined Physician type; they describe a distribution and say nothing about conduct.
Records
3 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Urogynecology and Reconstructive Pelvic Surgery in California
Bilal Kaaki
Urogynecology and Reconstructive Pelvic Surgery · Riverside, CA
Savitha Krishnan
Urogynecology and Reconstructive Pelvic Surgery · Mountain View, CA
Peter Castillo
Urogynecology and Reconstructive Pelvic Surgery · Los Gatos, CA
Bruce Kahn
Urogynecology and Reconstructive Pelvic Surgery · La Jolla, CA
Traci Ito
Urogynecology and Reconstructive Pelvic Surgery · San Francisco, CA
Tanaz Ferzandi
Urogynecology and Reconstructive Pelvic Surgery · Los Angeles, CA
Related records
Urogynecology and Reconstructive Pelvic Surgery in California
Practitioners in the same specialty and state, ranked by reported value.
All Urogynecology and Reconstructive Pelvic Surgery
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.